Sfoglia per AUTORE
MARCHETTI M
Collezione ASL Asti

  

Items : 28

2024
ASL Asti

Penack O; Marchetti M; Aljurf M; Arat M; Bonifazi F; Duarte RF; Giebel S; Greinix H; Hazenberg MD; Kröger N; Mielke S; Mohty M; Nagler A; Passweg J; Patriarca F; Ruutu T; Schoemans H; Solano C; Vrhovac R; Wolff D; Zeiser R; Sureda A; Peric Z;

Comparative Clinical Value of Pharmacologic Therapies for B-Cell Chronic Lymphocytic Leukemia: An Umbrella Analysis. in Journal of clinical medicine / J Clin Med. 2022 Mar 28;11(7):1868. doi: 10.3390/jcm11071868.
2022
ASL Asti
AOU Alessandria

Bertassello C; Rivela P; Marchetti M; Canicattì M;

Selecting ?-thalassemia Patients for Gene Therapy: A Decision-making Algorithm. in HemaSphere / Hemasphere. 2021 Apr 29;5(5):e555. doi: 10.1097/HS9.0000000000000555. eCollection 2021 May.
2021
ASL Asti
AOU San Luigi di Orbassano

Marchetti M; Pinto V; Rigano P; Origa R; Longo F; Graziadei G; De Franceschi L; Casale M; Baronciani D; Gigante A; Forni GL;

Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. in Hematological oncology / Hematol Oncol. 2021 Aug;39(3):326-335. doi: 10.1002/hon.2861. Epub 2021 Mar 26.
2021
ASL Asti
AOU Città della Salute di Torino

Foà R; Gentile M; Montillo M; Vignetti M; Crea E; Mauro FR; Marasca R; Marchetti M; Laurenti L; Quaglia FM; Molinari AL; Pietrasanta D; Varettoni M; Paolini R; Sportoletti P; Murru R; Farina L; Gaidano G; Vitagliano O; Coscia M; Zamprogna G; Cibien F; Reda G; Cuneo A; Visentin A; Arena V; Piciocchi A; Cavazzini F; Rigolin GM; et alii...

Frontline Siltuximab and Rituximab in TAFRO syndrome: A case report. in European journal of haematology / Eur J Haematol. 2020 Oct;105(4):505-507. doi: 10.1111/ejh.13473. Epub 2020 Jul 16.
2020
ASL Asti

Marchetti M; Feyles E; Zinzani P;

2020
ASL Asti
AOU Città della Salute di Torino

Foà R; Ghia P; Cucci R; Vignetti M; Cavallari M; Cimino G; Ferrarini I; de la Serna J; Medina Perez A; Mauro FR; Di Raimondo F; Coscia M; Molica S; Farina L; Doubek M; Gaidano G; Ilariucci F; Marchetti M; Tedeschi A; Spacek M; Trentin L; Billio A; Roeker L; Orlandi EM; Ujjani CS; Shah NN; Sehgal AR; Schuster SJ; Pu JJ; et alii...

2020
ASL Asti
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Larocca A; Romano A; Sonneveld P; Ria R; Musto P; Liberati AM; Offidani M; Giuliani N; Marchetti M; Mosca-Siez ML; de Fabritiis P; Gobbi M; Ballanti S; Cellini C; Grasso M; Monaco F; Ronconi S; Pescosta N; Di Lullo G; Capra A; Belotti A; Petrucci MT; Boccadoro M; Zambello R; Mina R;

Second cancers in MPN: Survival analysis from an international study. in American journal of hematology / Am J Hematol. 2020 Mar;95(3):295-301. doi: 10.1002/ajh.25700. Epub 2019 Dec 22.
2020
ASL Asti
AOU Città della Salute di Torino

Alvarez-Larran A; De Stefano V; Griesshammer M; Pane F; Recasens V; Isfort S; Tieghi A; McMullin MF; Cacciola R; Carli G; Benevolo G; Fox ML; Beggiato E; Angona A; Lunghi F; Perez-Encinas M; Wille K; Gomez M; Rapezzi D; Erez D; Palova M; Elli EM; Stephenson C; Guglielmelli P; Casetti IC; Patriarca A; Rumi E; Scaffidi L; Bonifacio M; et alii...

Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study. in HemaSphere / Hemasphere. 2020 Jun 8;4(3):e395. doi: 10.1097/HS9.0000000000000395. eCollection 2020 Jun.
2020
ASL Asti

Visentin A; Nasillo V; Marchetti M; Ferrarini I; Paolini R; Sancetta R; Rigolin GM; Cibien F; Riva M; Briani C; Marinello S; Piazza F; Gherlinzoni F; Krampera M; Bassan R; Cuneo A; Luppi M; Semenzato G; Marasca R; Trentin L;

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino

Barbui T; Rambaldi A; Vannucchi AM; Alvarez-Larran A; Griesshammer M; Marchetti M; Isfort S; Recasens V; Tieghi A; McMullin MF; Cacciola R; Carli G; Benevolo G; Beggiato E; Angona A; Fox ML; Lunghi F; Perez-Encinas M; Wille K; Gomez M; Erez D; Rapezzi D; Elli EM; Palova M; Guglielmelli P; Stephenson C; Casetti IC; Rumi E; Patriarca A; et alii...

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report. in Blood / Blood. 2020 Aug 6;136(6):763-766. doi: 10.1182/blood.2020006854.
2020
ASL Asti
AOU Città della Salute di Torino

Trentin L; Mauro FR; Gattei V; Ibatici A; Orsucci L; Rigolin GM; Pietrasanta D; Re F; De Paoli L; Marchetti M; Quaglia FM; Varettoni M; Reda G; Scarfò L; Cuneo A; Laurenti L; Marasca R; Foà R;

Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin. in Leukemia / Leukemia. 2020 Apr;34(4):1208-1209. doi: 10.1038/s41375-019-0616-4. Epub 2019 Nov 7.
2020
ASL Asti

Barbui T; Ghirardi A; Vannucchi AM; Marchetti M; De Stefano V;

HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Apr;105(4):1042-1054. doi: 10.3324/haematol.2019.217430. Epub 2019 Jul 9.
2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino

Coscia M; Foà R; Massaia M; Gaidano G; Bernardi R; Gattei V; Zenz T; Mauro FR; Del Poeta G; Laurenti L; Omedè P; Kodipad AA; Marchetti M; Bonello L; Magliulo D; Bo MD; Pozzato G; Rossi D; Bomben R; Riganti C; Salvetti C; Kopecka J; Todaro M; Vitale C; Griggio V; Boccadoro M;

Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology. in Leukemia research / Leuk Res. 2019 Jun;81:88-94. doi: 10.1016/j.leukres.2019.04.016. Epub 2019 May 2.
2019
ASL Asti

Zinzani PL; Rambaldi A; Gaidano G; Girmenia C; Marchetti M; Pane F; Tura S; Barosi G;

Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study. in Leukemia / Leukemia. 2019 Aug;33(8):1996-2005. doi: 10.1038/s41375-019-0487-8. Epub 2019 May 29.
2019
ASL Asti
AOU Città della Salute di Torino

Vannucchi AM; Griesshammer M; Alvarez-Larran A; Recasens V; Marchetti M; Tieghi A; Carli G; Cacciola R; McMullin MF; Benevolo G; Beggiato E; Fox ML; Perez-Encinas M; Lunghi F; Angona A; Wille K; Gomez M; Bertolotti L; Erez D; Palova M; Elli EM; Guglielmelli P; Stephenson C; Rumi E; Casetti IC; Patriarca A; Bonifacio M; Scaffidi L; Delaini F; et alii...

The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib. in British journal of haematology / Br J Haematol. 2018 Sep;182(5):701-704. doi: 10.1111/bjh.15450. Epub 2018 Jul 9.
2018
ASL Asti
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ferrero D; Boccadoro M; Mezzabotta M; Lanzarone G; Marchetti M; Cerrano M; Beggiato E; Frairia C; Pugliese N; Martinelli V; Palumbo GA; Elli EM; Cilloni D; Crisà E; Crisà E; Cilloni D; Elli EM; Martinelli V; Palumbo GA; Pugliese N; Beggiato E; Frairia C; Cerrano M; Lanzarone G; Marchetti M; Mezzabotta M; Boccadoro M; Ferrero D;

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet. in Leukemia / Leukemia. 2018 May;32(5):1057-1069. doi: 10.1038/s41375-018-0077-1. Epub 2018 Feb 27.
2018
ASL Asti

Barbui T; Tefferi A; Vannucchi AM; Passamonti F; Silver RT; Hoffman R; Verstovsek S; Mesa R; Kiladjian JJ; Hehlmann R; Reiter A; Cervantes F; Harrison C; Mc Mullin MF; Hasselbalch HC; Koschmieder S; Marchetti M; Bacigalupo A; Finazzi G; Kroeger N; Griesshammer M; Birgegard G; Barosi G;

Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: A systematic review. in American journal of hematology / Am J Hematol. 2018 May;93(5):698-703. doi: 10.1002/ajh.25049. Epub 2018 Feb 10.
2018
ASL Asti

Marchetti M; Carobbio A; Capitoni E; Barbui T;

2018
ASL Asti
AOU Città della Salute di Torino

Ghia P; Moreno C; Foà R; de la Serna J; Bowles KM; Vignetti M; Kennedy B; Schuh A; Eyre TA; Smolej L; Montillo M; Ciolli S; Cortelezzi A; Forconi F; Gonzalez M; Gaidano G; Molica S; Re F; Marchetti M; Ilariucci F; Meneghini V; Chiarenza A; Billio A; Marasca R; Visco C; Amendola A; Mauro FR; Galieni P; Orlandi EM; et alii...

Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study. in Blood / Blood. 2018 Aug 2;132(5):547-550. doi: 10.1182/blood-2018-03-835413. Epub 2018 Jun 13.
2018
ASL Asti

Rossi G; Gramegna D; Paoloni F; Fattizzo B; Binda F; D'Adda M; Farina M; Lucchini E; Mauro FR; Salvi F; Marchetti M; Fazi P; Zaja F; Barcellini W;

Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical review. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2017 Oct;17(5):469-480. doi: 10.1080/14737167.2017.1366858. Ep
2017
ASL Asti

Marchetti M;

Identification of new BMP6 pro-peptide mutations in patients with iron overload. in American journal of hematology / Am J Hematol. 2017 Jun;92(6):562-568. doi: 10.1002/ajh.24730. Epub 2017 Apr 29.
2017
ASL Asti
AOU San Luigi di Orbassano

Delledonne M; Olivieri O; Suku E; Giorgetti A; Xumerle L; Roetto A; Marchetti M; De Gobbi M; Badar S; Busti F; Rizzi M; Marchi G; Castagna A; Piubelli C; Girelli D;

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations. in Leukemia / Leukemia. 2017 Apr;31(4):882-888. doi: 10.1038/leu.2016.283. Epub 2016 Oct 14.
2017
ASL Asti

Marchetti M; Barosi G; Cervantes F; Birgegård G; Griesshammer M; Harrison C; Hehlmann R; Kiladjian JJ; Kröger N; McMullin MF; Passamonti F; Vannucchi A; Barbui T;

Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a systematic and qualitative review. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):221-35. doi: 10.1586/14737167.2016.1147351. Epub 20
2016
ASL Asti

Liberato NL; Marchetti M;

2015
ASL Asti
AO Ordine Mauriziano
AOU Città della Salute di Torino

Tura S; Marchetti M; Rambaldi A; Vitolo U; Billio A; Arcaini L; Baldini L; Barosi G; Tarella C; Zinzani PL;

Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey. in Cytotherapy / Cytotherapy. 2014 Jan;16(1):101-10. doi: 10.1016/j.jcyt.2013.07.001. Epub 2013 Oct 26.
2014
ASL Asti

Olivieri J; Pierelli L; Introna M; Accorsi P; Bosi A; Perseghin P; Risso M; Pandolfi A; Mancini S; Marchetti M; Dal Pozzo S; Gotti E; Rambaldi A; Leoni P; Olivieri A;

Biological therapies in Crohn's disease: are they cost-effective? A critical appraisal of model-based analyses. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):815-24. doi: 10.1586/14737167.2014.957682. Epub
2014
ASL Asti

Marchetti M; Liberato NL;

Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn's disease. in The European journal of health economics : HEPAC : health economics in prevention and care / Eur J Health Econ. 2013 Dec;14(6):853-61. doi: 10.1007/s10198-012-0430-7. Epub 2012 Sep 14.
2013
ASL Asti

Marchetti M; Liberato NL; Di Sabatino A; Corazza GR;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte